CTOs on the Move

Acucela

www.acucela.com

 
Acucela is a clinical-stage biotechnology company that specializes in discovering and developing novel therapeutics to treat and slow the progression of sight-threatening ophthalmic diseases impacting millions of individuals worldwide. Acucela currently has the following candidates in development with Otsuka Pharmaceutical: emixustat hydrochloride for GA associated with dry AMD based on Acucela’s proprietary visual cycle modulation; and OPA-6566 for ocular hypertension and glaucoma.
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million
  • www.acucela.com
  • 1301 2nd Ave # 1900
    Seattle, WA USA 98101
  • Phone: 206.805.8300

Executives

Name Title Contact Details

Similar Companies

Sterling Pharmaceutical Services

Sterling Pharmaceutical Services is a Maryville, IL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Welcome Nursing Home Inc

Welcome Nursing Home Inc is a Oberlin, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Palo Duro Nursing Home

Palo Duro Nursing Home is a Claude, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Sarah Cannon Research Institute

SCRI, an industry leader in clinical trials, is dedicated to advancing therapies for patients through clinical research.

Hello Heart

Hello Heart is a digital program that empowers people to understand and improve their heart health - the #1 cost factor for employers.